West Pharma

Global Communications

June 12, 2014

West Offers Innovative and Reliable Solutions at Pre-Filled Syringe Technology Seminars

In recent seminars in Hyderabad and Ahmedabad, India, West’s Tibor Hlobik discussed the challenges faced by injectable drug manufacturers to minimize risk, accelerate product development, ensure patient safety and improve ease of administration. Similar seminars were held in China and Korea.

“Companies must differentiate their new products within therapeutic categories that are very competitive,” said Hlobik. “Prefillable syringes and cartridges offer many benefits as compared to vial formats, including precise dose accuracy, less drug overfill for lower unit cost, and drug product differentiation.”

West organized the seminar to discuss innovative solutions on prefilled syringe, cartridge and safety devices. Hlobik shared his in-depth knowledge and experience in elastomeric components and accessories to support new applications. The presentation also emphasized minimizing risk by selecting the modern formulations, ready-to-use sterile components and 100% vision verification for stringent quality requirements.

Topics discussed included:

  • Elastomer technology for prefilled syringe applications
  • Solutions in prefilled syringe components such as tip caps, needle shields, plungers and back stop.
  • Westar® ready-to-use and ready-to-sterilize components
  • FluroTec® barrier film, a technology that can improve the compatibility of the closure and the drug, minimizing the risk of extractables and leachables
  •  NovaPure® components, which have been designed and manufactured through a process using Quality by Design principle to mitigate risk for the pharmaceutical company and the patient
  • Trends in lined seals and plungers used for cartridge-based drug delivery
  • Solutions for preventing needlestick injuries, such as the NovaGuard® SA Safety System

More than 80 representatives from leading pharmaceutical companies, especially in injectable dosage, participated in the seminar in Hyderabad.

NovaPure, NovaGuard, Westar and FluroTec are registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.  FluroTec technology is licensed from Daikyo Seiko, Ltd.

West seeks partners for the NovaGuard SA technology platform as an integrated system. Final assembly is completed by the pharmaceutical company.